Literature DB >> 24634693

Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.

Carmen Pittman1, Sabrina Plitt1, Ted Birse2, Karen Doucette3, Barbara Romanowski3, Rya Cooper3, Stan Houston3, Stephen Shafran3, Ameeta E Singh3.   

Abstract

BACKGROUND: HIV and hepatitis B virus (HBV) share transmission routes, and coinfection is associated with higher morbidity and mortality. To date, no Canadian studies have examined HIV-HBV coinfection.
OBJECTIVES: To examine the prevalence and correlates of HIV and HBV coinfections in Northern Alberta.
METHODS: The present study was a retrospective database review of all HIV-infected (HIV+) individuals in Northern Alberta from 1982 to 2010 and a chart review of HBV surface antigen-positive individuals for whom charts were available (46.2%).
RESULTS: Of 2844 HIV+ patients, 2579 (90.7%) had been tested for HBV surface antigen, and 143 (5.5%) of these were HBV coinfected. Coinfected males were primarily Caucasian (70.8%), and coinfected females were primarily black (56.4%) or Aboriginal (31.3%). Coinfected individuals were more likely to be male (88.1% versus 71.3%; P<0.001) and to have died (34.3% versus 17.9%; P<0.001).
CONCLUSIONS: The prevalence of coinfection with HBV in HIV-infected patients in Northern Alberta is lower than reported in other developed nations. The pattern of coinfections in Northern Alberta likely follows immigration trends. Recognition and management may be improving with time; however, further research and additional strategies are required to enhance the prevention, identification and management of HBV infection in HIV-infected individuals.

Entities:  

Keywords:  Alberta; Canada; Coinfection; HIV; Hepatitis B

Year:  2014        PMID: 24634693      PMCID: PMC3950981          DOI: 10.1155/2014/971546

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  38 in total

1.  Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.

Authors:  R J Gilson; A E Hawkins; M R Beecham; E Ross; J Waite; M Briggs; T McNally; G E Kelly; R S Tedder; I V Weller
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

2.  Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.

Authors:  R J Biggar; J J Goedert; J Hoofnagle
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

3.  Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.

Authors:  P R Spradling; J T Richardson; K Buchacz; A C Moorman; J T Brooks
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

4.  Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.

Authors:  Vincent Soriano; Pablo Barreiro; Luz Martín-Carbonero; Carol Castellares; Andres Ruiz-Sancho; Pablo Labarga; Belen Ramos; Juan Gonzalez-Lahoz
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

5.  Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.

Authors:  Susan E Buskin; Elizabeth A Barash; John D Scott; David M Aboulafia; Robert W Wood
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 6.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

7.  Management of chronic hepatitis B: consensus guidelines.

Authors:  Morris Sherman; Stephen Shafran; Kelly Burak; Karen Doucette; Winnie Wong; Nigel Girgrah; Eric Yoshida; Eberhard Renner; Philip Wong; Marc Deschênes
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

8.  Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis.

Authors:  Georgios K Nikolopoulos; Dimitrios Paraskevis; Eleni Hatzitheodorou; Zissis Moschidis; Vana Sypsa; Xenophon Zavitsanos; Victoria Kalapothaki; Angelos Hatzakis
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

9.  Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.

Authors:  Gary M Clifford; Martin Rickenbach; Jerry Polesel; Luigino Dal Maso; Ingrid Steffen; Bruno Ledergerber; Andri Rauch; Nicole M Probst-Hensch; Christine Bouchardy; Fabio Levi; Silvia Franceschi
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

Review 10.  Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?

Authors:  J D Ni; Y Z Xiong; X J Wang; L C Xiu
Journal:  Int J STD AIDS       Date:  2013-05-06       Impact factor: 1.359

View more
  3 in total

1.  Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital.

Authors:  Abraham Goa; Tadele Dana; Shimelash Bitew; Aseb Arba
Journal:  Hepat Med       Date:  2019-09-06

2.  Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.

Authors:  Ifeyinwa Dorothy Nnakenyi; Chisom Uchechukwu; Uloaku Nto-Ezimah
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

3.  Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?

Authors:  Urvi Rana; Matt Driedger; Paul Sereda; Shenyi Pan; Erin Ding; Alex Wong; Sharon Walmsley; Marina Klein; Deborah Kelly; Mona Loutfy; Rejean Thomas; Stephen Sanche; Abigail Kroch; Nima Machouf; Marie-Helene Roy-Gagnon; Robert Hogg; Curtis L Cooper
Journal:  BMC Infect Dis       Date:  2019-11-21       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.